A comparison of the binding sites of antibodies and single-domain antibodies

被引:6
|
作者
Gordon, Gemma L. [1 ]
Capel, Henriette L. [1 ]
Guloglu, Bora [1 ]
Richardson, Eve [1 ]
Stafford, Ryan L. [2 ]
Deane, Charlotte M. [1 ]
机构
[1] Univ Oxford, Dept Stat, Oxford Prot Informat Grp, Oxford, England
[2] Twist Biosci, South San Francisco, CA USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
英国医学研究理事会; 英国惠康基金; 英国工程与自然科学研究理事会;
关键词
single-domain antibody; antibodies; binding; paratope; epitope; structural biology; biologics; PROTEIN; TOOLS;
D O I
10.3389/fimmu.2023.1231623
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies are the largest class of biotherapeutics. However, in recent years, single-domain antibodies have gained traction due to their smaller size and comparable binding affinity. Antibodies (Abs) and single-domain antibodies (sdAbs) differ in the structures of their binding sites: most significantly, single-domain antibodies lack a light chain and so have just three CDR loops. Given this inherent structural difference, it is important to understand whether Abs and sdAbs are distinguishable in how they engage a binding partner and thus, whether they are suited to different types of epitopes. In this study, we use non-redundant sequence and structural datasets to compare the paratopes, epitopes and antigen interactions of Abs and sdAbs. We demonstrate that even though sdAbs have smaller paratopes, they target epitopes of equal size to those targeted by Abs. To achieve this, the paratopes of sdAbs contribute more interactions per residue than the paratopes of Abs. Additionally, we find that conserved framework residues are of increased importance in the paratopes of sdAbs, suggesting that they include non-specific interactions to achieve comparable affinity. Furthermore, the epitopes of sdAbs are only marginally less accessible than those of Abs: we posit that this may be explained by differences in the orientation and compaction of sdAb and Ab CDR-H3 loops. Overall, our results have important implications for the engineering and humanization of sdAbs, as well as the selection of the best modality for targeting a particular epitope.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Immunogenicity and humanization of single-domain antibodies
    Rossotti, Martin A.
    Belanger, Kasandra
    Henry, Kevin A.
    Tanha, Jamshid
    [J]. FEBS JOURNAL, 2022, 289 (14) : 4304 - 4327
  • [2] Single-domain antibodies make a difference
    Saelens, Xavier
    Schepens, Bert
    [J]. SCIENCE, 2021, 371 (6530) : 681 - 682
  • [3] Single-Domain Antibodies for Brain Targeting
    Lalatsa, Aikaterini
    Leite, Diana M.
    [J]. BIOPHARM INTERNATIONAL, 2014, 27 (08) : 20 - 26
  • [4] Single-domain antibodies for biomedical applications
    Krah, Simon
    Schroeter, Christian
    Zielonka, Stefan
    Empting, Martin
    Valldorf, Bernhard
    Kolmar, Harald
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (01) : 21 - 28
  • [5] Nanobodies: Natural Single-Domain Antibodies
    Muyldermans, Serge
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82, 2013, 82 : 775 - 797
  • [6] Advantages of single-domain antigen-binding fragments derived from functional camel heavy-chain antibodies. Camel single-domain antibodies
    Serge, M
    Katja, C
    Bang, VK
    Teresa, S
    Magnus, B
    Natasha, B
    Karen, S
    Marc, L
    Aline, D
    [J]. NOVEL FRONTIERS IN THE PRODUCTION OF COMPOUNDS FOR BIOMEDICAL USE, VOL 1, 2001, 1 : 209 - 216
  • [7] Physicochemical differences between camelid single-domain antibodies and mammalian antibodies
    Eskier, Nazli Eda
    Eskier, Doga
    Firuzan, Esin
    Uzunlar, Sibel Kalyoncu
    [J]. TURKISH JOURNAL OF BIOLOGY, 2023, 47 (06)
  • [8] Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies
    Khodabakhsh, Farnaz
    Behdani, Mahdi
    Rami, Abbas
    Kazemi-Lomedasht, Fatemeh
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2018, 37 (06) : 316 - 322
  • [9] Prospective Applications of Single-Domain Antibodies in Biomedicine
    S. V. Tillib
    [J]. Molecular Biology, 2020, 54 : 317 - 326
  • [10] Single-domain antibodies tackle COVID variants
    Voss, James E.
    [J]. NATURE, 2021, 595 (7866) : 176 - 178